93 related articles for article (PubMed ID: 8098933)
21. AIDS-related vacuolar myelopathy is not associated with coinfection by human T-lymphotropic virus type I.
Brew BJ; Hardy W; Zuckerman E; Chien N; Paul M; Rosenblum M; Gadler H; Vahlne A; Gold J; Armstrong DA
Ann Neurol; 1989 Nov; 26(5):679-81. PubMed ID: 2817843
[TBL] [Abstract][Full Text] [Related]
22. Lymphocyte-endothelial cell interactions in multiple sclerosis: disease specificity and relationship to circulating tumour necrosis factor-alpha and soluble adhesion molecules.
Vora AJ; Kidd D; Miller DH; Perkin GD; Hughes RA; Ellis BA; Dumonde DC; Brown KA
Mult Scler; 1997 Jun; 3(3):171-9. PubMed ID: 9310962
[TBL] [Abstract][Full Text] [Related]
23. Serum levels of apoptosis-related molecules in patients with multiple sclerosis and human T-lymphotropic virus Type I-associated myelopathy.
Sakai T; Inoue A; Koh CS; Osame M
J Interferon Cytokine Res; 1999 Sep; 19(9):999-1004. PubMed ID: 10505741
[TBL] [Abstract][Full Text] [Related]
24. Soluble E-selectin in the serum and cerebrospinal fluid of patients with multiple sclerosis and human T-lymphotropic virus type 1-associated myelopathy.
Tsukada N; Miyagi K; Matsuda M; Yanagisawa N
Neurology; 1995 Oct; 45(10):1914-8. PubMed ID: 7477992
[TBL] [Abstract][Full Text] [Related]
25. Absence of antibody to HTLV I and III in sera of Canadian patients with multiple sclerosis and chronic myelopathy.
Rice GP; Armstrong HA; Bulman DE; Paty DW; Ebers GC
Ann Neurol; 1986 Oct; 20(4):533-4. PubMed ID: 2878638
[TBL] [Abstract][Full Text] [Related]
26. [Intercellular adhesion molecules sICAM-1, sICAM-2, sICAM-3 and IFNgamma in neuroborreliosis and tick-borne encephalitis].
Pietruczuk M; Pietruczuk A; Pancewicz S; Zajkowska J; Swierzbińska R; Hermanowska-Szpakowicz T
Przegl Epidemiol; 2006; 60 Suppl 1():109-17. PubMed ID: 16909787
[TBL] [Abstract][Full Text] [Related]
27. Increased levels of soluble vascular cell adhesion molecule-1 (VCAM-1) in the cerebrospinal fluid and sera of patients with multiple sclerosis and human T lymphotropic virus type-1-associated myelopathy.
Matsuda M; Tsukada N; Miyagi K; Yanagisawa N
J Neuroimmunol; 1995 Jun; 59(1-2):35-40. PubMed ID: 7541057
[TBL] [Abstract][Full Text] [Related]
28. Detection of the soluble form of the Fas molecule in patients with multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy.
Inoue A; Koh CS; Sakai T; Yamazaki M; Yanagisawa N; Usuku K; Osame M
J Neuroimmunol; 1997 May; 75(1-2):141-6. PubMed ID: 9143247
[TBL] [Abstract][Full Text] [Related]
29. [Myelopathy, polymyositis and systemic manifestations associated with the HTLV-I virus].
Masson C; Chaunu MP; Hénin D; Masson M; Cambier J
Rev Neurol (Paris); 1989; 145(12):838-41. PubMed ID: 2694285
[TBL] [Abstract][Full Text] [Related]
30. Soluble intercellular adhesion molecule-I (sICAM-I) in serum and cerebrospinal fluid of demyelinating diseases of the central and peripheral nervous system.
Trojano M; Avolio C; Ruggieri M; De Robertis F; Giuliani F; Paolicelli D; Livrea P
Mult Scler; 1998 Feb; 4(1):39-44. PubMed ID: 9532592
[TBL] [Abstract][Full Text] [Related]
31. Serial analysis of soluble intercellular adhesion molecule-1 level in relapsing-remitting multiple sclerosis patients during IFN-beta1b treatment.
Kilinc M; Saatci-Cekirge I; Karabudak R
J Interferon Cytokine Res; 2003 Mar; 23(3):127-33. PubMed ID: 12716484
[TBL] [Abstract][Full Text] [Related]
32. Thrombomodulin in the sera of patients with multiple sclerosis and human lymphotropic virus type-1-associated myelopathy.
Tsukada N; Matsuda M; Miyagi K; Yanagisawa N
J Neuroimmunol; 1995 Jan; 56(1):113-6. PubMed ID: 7822477
[TBL] [Abstract][Full Text] [Related]
33. [Elevated serum levels of ICAM-1 in Wegener's granulomatosis].
Hauschild S; Schmitt WH; Kekow J; Szymkowiak C; Gross WL
Immun Infekt; 1992 Jul; 20(3):84-5. PubMed ID: 1354197
[TBL] [Abstract][Full Text] [Related]
34. [An analysis of lymphocyte surface markers in HTLV-I-associated myelopathy (HAM)].
Kuwasaki N; Yasuda K; Shoji H; Kaji M; Ayabe M
Rinsho Shinkeigaku; 1988 Oct; 28(10):1192-6. PubMed ID: 3265368
[No Abstract] [Full Text] [Related]
35. Serum and cerebrospinal fluid levels of soluble intercellular adhesion molecule 1 (sICAM-1) in patients with HIV-1 associated neurological diseases.
Heidenreich F; Arendt G; Jander S; Jablonowski H; Stoll G
J Neuroimmunol; 1994 Jul; 52(2):117-26. PubMed ID: 7913474
[TBL] [Abstract][Full Text] [Related]
36. Increased levels of soluble tumor necrosis factor receptor in patients with multiple sclerosis and HTLV-1-associated myelopathy.
Matsuda M; Tsukada N; Miyagi K; Yanagisawa N
J Neuroimmunol; 1994 Jun; 52(1):33-40. PubMed ID: 8207119
[TBL] [Abstract][Full Text] [Related]
37. In vitro modulation of lymphocyte proliferation by prednisolone and interferon-alpha in patients with HTLV-I-associated myelopathy (HAM).
Ijichi S; Eiraku N; Osame M; Izumo S; Kubota R; Maruyama I; Matsumoto M; Sonoda S
J Neuroimmunol; 1989 Jul; 23(2):175-8. PubMed ID: 2723044
[TBL] [Abstract][Full Text] [Related]
38. Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosis.
Khoury SJ; Orav EJ; Guttmann CR; Kikinis R; Jolesz FA; Weiner HL
Neurology; 1999 Sep; 53(4):758-64. PubMed ID: 10489037
[TBL] [Abstract][Full Text] [Related]
39. Serum levels of intercellular adhesion molecule 1 in patients with HIV-related Kaposi's sarcoma.
De Paoli P; Caffau C; D'Andrea M; Tavio M; Tirelli U; Santini G
J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):695-9. PubMed ID: 7911526
[TBL] [Abstract][Full Text] [Related]
40. Increased serum levels of ICAM-1, ELAM-1 and TNF-alpha in inflammatory disorders of the peripheral nervous system.
Musso AM; Zanusso GL; Bonazzi ML; Tomelleri G; Bonetti B; Moretto G; Vio M; Monaco S
Ital J Neurol Sci; 1994 Sep; 15(6):267-71. PubMed ID: 7531188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
